BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37626373)

  • 1. Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro.
    Cucinotta L; Mannino D; Casili G; Repici A; Crupi L; Paterniti I; Esposito E; Campolo M
    Respir Res; 2023 Aug; 24(1):211. PubMed ID: 37626373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease.
    Myöhänen TT; Hannula MJ; Van Elzen R; Gerard M; Van Der Veken P; García-Horsman JA; Baekelandt V; Männistö PT; Lambeir AM
    Br J Pharmacol; 2012 Jun; 166(3):1097-113. PubMed ID: 22233220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor as a Novel Therapeutic Tool for Lung Injury.
    Fusco R; Siracusa R; D'Amico R; Cordaro M; Genovese T; Gugliandolo E; Peritore AF; Crupi R; Di Paola R; Cuzzocrea S; Impellizzeri D
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion.
    Casili G; Scuderi SA; Lanza M; Filippone A; Basilotta R; Mannino D; Campolo M; Esposito E; Paterniti I
    Oncotarget; 2021 Aug; 12(17):1663-1676. PubMed ID: 34434495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-κB signaling pathways.
    Xiong Y; Cui X; Zhou Y; Chai G; Jiang X; Ge G; Wang Y; Sun H; Che H; Nie Y; Zhao P
    Int Immunopharmacol; 2021 Sep; 98():107780. PubMed ID: 34118645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation.
    Scuderi SA; Casili G; Ardizzone A; Forte S; Colarossi L; Sava S; Paterniti I; Esposito E; Cuzzocrea S; Campolo M
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse.
    Savolainen MH; Richie CT; Harvey BK; Männistö PT; Maguire-Zeiss KA; Myöhänen TT
    Neurobiol Dis; 2014 Aug; 68():1-15. PubMed ID: 24746855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prolyl Oligopeptidase Inhibitor KYP-2047 Is Cytoprotective and Anti-Inflammatory in Human Retinal Pigment Epithelial Cells with Defective Proteasomal Clearance.
    Toppila M; Hytti M; Korhonen E; Ranta-Aho S; Harju N; Forsberg MM; Kaarniranta K; Jalkanen A; Kauppinen A
    Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37372009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
    Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
    Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinapic acid ameliorates bleomycin-induced lung fibrosis in rats.
    Raish M; Ahmad A; Ahmad Ansari M; Ahad A; Al-Jenoobi FI; Al-Mohizea AM; Khan A; Ali N
    Biomed Pharmacother; 2018 Dec; 108():224-231. PubMed ID: 30219680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Inhibition of Prolyl Oligopeptidase as New Target to Counteract Chronic Venous Insufficiency: Findings in a Mouse Model.
    Casili G; Lanza M; Scuderi SA; Messina S; Paterniti I; Campolo M; Esposito E
    Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33322134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells.
    Rostami J; Jäntti M; Cui H; Rinne MK; Kukkonen JP; Falk A; Erlandsson A; Myöhänen T
    Biomed Pharmacother; 2020 Nov; 131():110788. PubMed ID: 33152946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Prolyl Oligopeptidase Prevents Consequences of Reperfusion following Intestinal Ischemia.
    Filippone A; Casili G; Ardizzone A; Lanza M; Mannino D; Paterniti I; Esposito E; Campolo M
    Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma.
    Scuderi SA; Casili G; Filippone A; Lanza M; Basilotta R; Giuffrida R; Munaò S; Colarossi L; Capra AP; Esposito E; Paterniti I
    Oncotarget; 2021 Dec; 12(25):2459-2473. PubMed ID: 34917264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine alleviates pulmonary alveolar proteinosis induced by indium-tin oxide nanoparticles in male rats: involvement of the NF-κB signaling pathway.
    Liu N; Li G; Guan Y; Wang R; Ma Z; Zhao L; Yao S
    Ecotoxicol Environ Saf; 2022 Aug; 241():113812. PubMed ID: 36068741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway.
    Li XH; Xiao T; Yang JH; Qin Y; Gao JJ; Liu HJ; Zhou HG
    Respir Res; 2018 Jun; 19(1):111. PubMed ID: 29871641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-allyl-l-cysteine attenuates bleomycin-induced pulmonary fibrosis and inflammation via AKT/NF-κB signaling pathway in mice.
    Nie Y; Yu K; Li B; Hu Y; Zhang H; Xin R; Xiong Y; Zhao P; Chai G
    J Pharmacol Sci; 2019 Apr; 139(4):377-384. PubMed ID: 30928090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model.
    Eteläinen TS; Kilpeläinen TP; Ignatius A; Auno S; De Lorenzo F; Uhari-Väänänen JK; Julku UH; Myöhänen TT
    Neuropharmacology; 2022 Nov; 218():109213. PubMed ID: 35964686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naja naja atra venom ameliorates pulmonary fibrosis by inhibiting inflammatory response and oxidative stress.
    Cui K; Kou JQ; Gu JH; Han R; Wang G; Zhen X; Qin ZH
    BMC Complement Altern Med; 2014 Dec; 14():461. PubMed ID: 25465226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β.
    Kandhare AD; Bodhankar SL; Mohan V; Thakurdesai PA
    Chem Biol Interact; 2015 Jul; 237():151-65. PubMed ID: 26093215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.